 |
Topo IIβ (F-19) Antibody: sc-5353 |
| Datasheet |
|
- goat polyclonal IgG, 200 µg/ml
- epitope mapping near the C-terminus of Topo IIβ of human origin
- recommended for detection of DNA Topoisomerase IIβ of mouse, rat and human origin by WB, IP, IF and ELISA; also reactive with additional species, including equine, canine and bovine
- blocking peptide, sc-5353 P
|
|
| |
Ordering Information
Recommended Support Products:
(click button of application of choice)
| |
| Species |
Gene Name |
Gene ID |
Chromosome Location |
Isoform (mRNA) Accession # |
Protein Accession # |
OMIM™ Number |
| Human |
TOP2B |
7155 |
3p24.2 |
NM_001068 |
Q02880
|
126431 |
| Mouse |
Top2b |
21974 |
14 A2 |
|
Q64511
|
N/A |
| |
Topo IIβ Background Information DNA topoisomerase I and II (Topo I and Topo II) are nuclear enzymes that regulate the topological structure of DNA in eukaryotic cells by transiently breaking and rejoining DNA strands. Eukaryotic topoisomerases are capable of relaxing both positive and negative supercoils, whereas prokaryotic topoisomerases relax only negative supercoils. DNA topoisomerases play a role in DNA replication, recombination and transcription, and have been identified as targets of numerous anticancer drugs. Topo I, a ubiquitously expressed, soluble enzyme, acts by introducing a transient break in one strand of DNA, while Topo II acts by making a transient double-strand break. Topo II is encoded by two different genes to generate two distinct isoforms that are designated Topo IIå and Topo II∫. Topo IIå and Topo II∫ are largely homologous at their N-terminal three quarters, however, the C-terminal segments are considerably divergent, suggesting that these regions may mediate different cellular functions and account for the observed differential tissue expression patterns of the two isoforms. |
 |
|
Topo IIβ (F-19)
Click on image to enlarge
|
|
Topo IIβ (F-19): sc-5353. Western blot analysis of Topo IIβ expression in U-937 (A), MEG-01 (B), CCRF-CEM (C) and HeLa (D) nuclear extracts.
|
|
Download
|
|